Product image of Lacosamida Generis (Lacosamide) supplied by GNH India

Lacosamida Generis

Active Ingredient:
Lacosamide
Origin:
EU

Lacosamida Generis (Lacosamide)

Lacosamide, the active ingredient in Lacosamida Generis, is an anticonvulsant presented as an intravenous solution for intravenous use. It is employed to treat partial‑onset seizures in patients with epilepsy.
GNH India supplies Lacosamida Generis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Eugia Pharma (Malta) Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lacosamide is an anticonvulsant that modulates neuronal excitability in focal epilepsy.

  • Partial‑onset seizures: reduces seizure frequency when used as adjunctive therapy.
  • Adjunctive therapy in epilepsy: improves overall seizure control in patients not fully managed by other agents.
  • Refractory focal epilepsy: provides an additional mechanism of action for patients with inadequate response to standard treatments.

How It Works

  • Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing hyper‑excitable neuronal membranes and limiting repetitive firing. This selective modulation reduces the propagation of epileptic discharges without significantly affecting normal neuronal activity.

Side Effects

Lacosamide may cause a range of adverse reactions.

Common Side Effects

  • Dizziness: mild to moderate sensation of light‑headedness.
  • Headache: transient cranial discomfort.
  • Nausea: occasional upset stomach.
  • Fatigue: feeling of tiredness or reduced energy.
  • Diplopia: temporary double vision.
  • Somnolence: increased sleepiness.

Serious or Rare Side Effects

  • Cardiac arrhythmia (PR‑interval prolongation): may affect heart rhythm.
  • Atrial fibrillation: irregular heart beat in susceptible individuals.
  • Severe skin reactions (e.g., Stevens‑Johnson syndrome): requires immediate medical attention.
  • Hypersensitivity reactions: rash, swelling, or anaphylaxis.
  • Suicidal ideation: emergence of thoughts of self‑harm.
  • Elevated hepatic enzymes: potential liver function alteration.

Precautions & Warnings

When prescribing Lacosamide, consider the following precautions.

  • Renal impairment: adjust dosing in patients with reduced kidney function.
  • Hepatic impairment: monitor liver function and consider dose modification.
  • Cardiac conduction disorders: avoid in patients with pre‑existing PR‑interval prolongation.
  • Concomitant sodium‑channel blockers: increased risk of CNS depression.
  • Pregnancy: safety not established; weigh benefits against potential risks.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Lacosamide can interact with several medications.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., carbamazepine, phenytoin, rifampin): may markedly reduce lacosamide levels.
  • Other sodium‑channel blockers (e.g., lamotrigine, valproate): increase risk of CNS depression.
  • QT‑prolonging agents: potential additive effect on cardiac repolarization.

Moderate Interactions (Monitor Closely)

  • CYP2C19 inhibitors (e.g., fluconazole, omeprazole): may increase lacosamide exposure.
  • Alcohol: can enhance sedative effects.
  • Anticoagulants (e.g., warfarin): monitor coagulation parameters as interaction is possible.

Frequently Asked Questions

Lacosamida Generis contains lacosamide, an anticonvulsant indicated for the treatment of partial‑onset (focal) seizures in patients with epilepsy. It is used as an adjunctive therapy to improve seizure control when other medications are insufficient.

Lacosamide enhances the slow inactivation of voltage‑gated sodium channels in neuronal membranes. This stabilizes hyper‑excitable neurons, reduces repetitive firing, and limits the spread of epileptic activity without markedly affecting normal neuronal signaling.

The dosage of Lacosamida Generis is individualized by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and response to therapy. The prescriber determines the appropriate dose and titration schedule.

Safety of lacosamide in pregnancy and lactation has not been fully established. The prescriber should weigh potential benefits against possible risks and consider alternative therapies when treating pregnant or nursing patients.

To request Lacosamida Generis, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Lacosamide offers a distinct mechanism by enhancing slow sodium‑channel inactivation, which differs from many traditional antiepileptics that target fast inactivation. This can provide additive seizure control when combined with other agents, especially in patients with refractory focal seizures.

Lacosamida Generis should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain stability.

The product is supplied as an intravenous solution and is administered by slow infusion into a vein under medical supervision. The rate and duration of infusion are determined by the treating physician according to clinical guidelines.

Serious risks include cardiac arrhythmias such as PR‑interval prolongation or atrial fibrillation, severe skin reactions like Stevens‑Johnson syndrome, hypersensitivity reactions, and rare cases of suicidal ideation. Patients should be monitored for these events, especially during treatment initiation.

Lacosamida Generis is contraindicated in patients with known hypersensitivity to lacosamide or any formulation components, and should be used with caution in individuals with significant cardiac conduction abnormalities, severe renal or hepatic impairment, or those taking interacting medications that may increase toxicity.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lacosamide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT